146 related articles for article (PubMed ID: 14599410)
1. [Paraoxonase, something more than an enzyme?].
Canales A; Sánchez-Muniz FJ
Med Clin (Barc); 2003 Oct; 121(14):537-48. PubMed ID: 14599410
[TBL] [Abstract][Full Text] [Related]
2. [Paraoxonase--important enzyme of the lipid metabolism and potential ally in the antiatherosclerotic treatment].
Sapian-Raczkowska B; Rabczyński M; Adamiec R
Pol Merkur Lekarski; 2010 Nov; 29(173):325-7. PubMed ID: 21268919
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of paraoxonase genes and low-density lipoprotein lipid peroxidation.
Mackness B; Durrington PN; Mackness MI
Lancet; 1999 Feb; 353(9151):468-9. PubMed ID: 9989726
[No Abstract] [Full Text] [Related]
4. Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q-->R genetic polymorphism.
Cao H; Girard-Globa A; Berthezene F; Moulin P
J Lipid Res; 1999 Jan; 40(1):133-9. PubMed ID: 9869659
[TBL] [Abstract][Full Text] [Related]
5. Alloenzymes of paraoxonase and effectiveness of high-density lipoproteins in protecting low-density lipoprotein against lipid peroxidation.
Mackness MI; Arrol S; Mackness B; Durrington PN
Lancet; 1997 Mar; 349(9055):851-2. PubMed ID: 9121268
[No Abstract] [Full Text] [Related]
6. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
[TBL] [Abstract][Full Text] [Related]
7. Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation.
Boemi M; Leviev I; Sirolla C; Pieri C; Marra M; James RW
Atherosclerosis; 2001 Mar; 155(1):229-35. PubMed ID: 11223446
[TBL] [Abstract][Full Text] [Related]
8. How high-density lipoprotein protects against the effects of lipid peroxidation.
Mackness MI; Durrington PN; Mackness B
Curr Opin Lipidol; 2000 Aug; 11(4):383-8. PubMed ID: 10945720
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase gene polymorphisms, oxidative stress, and diseases.
Li HL; Liu DP; Liang CC
J Mol Med (Berl); 2003 Dec; 81(12):766-79. PubMed ID: 14551701
[TBL] [Abstract][Full Text] [Related]
10. Paraoxonase-gene polymorphisms associated with coronary heart disease: support for the oxidative damage hypothesis?
Heinecke JW; Lusis AJ
Am J Hum Genet; 1998 Jan; 62(1):20-4. PubMed ID: 9443884
[No Abstract] [Full Text] [Related]
11. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females.
Ferretti G; Bacchetti T; Moroni C; Savino S; Liuzzi A; Balzola F; Bicchiega V
J Clin Endocrinol Metab; 2005 Mar; 90(3):1728-33. PubMed ID: 15613429
[TBL] [Abstract][Full Text] [Related]
12. Paraoxonase genotype, LDL-oxidation and carotid atherosclerosis in male life-long smokers.
Van Himbergen T; Roest M; De Waart F; De Graaf J; Voorbij H; Van Tits L; Stalenhoef A
Free Radic Res; 2004 Jun; 38(6):553-60. PubMed ID: 15346646
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of paraoxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: a comparison between healthy subjects and type 1 diabetic patients.
Ferretti G; Bacchetti T; Busni D; Rabini RA; Curatola G
J Clin Endocrinol Metab; 2004 Jun; 89(6):2957-62. PubMed ID: 15181084
[TBL] [Abstract][Full Text] [Related]
14. Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.
Navab M; Hama-Levy S; Van Lenten BJ; Fonarow GC; Cardinez CJ; Castellani LW; Brennan ML; Lusis AJ; Fogelman AM; La Du BN
J Clin Invest; 1997 Apr; 99(8):2005-19. PubMed ID: 9109446
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase 1 activity, concentration and genotype in cardiovascular disease.
Mackness M; Durrington P; Mackness B
Curr Opin Lipidol; 2004 Aug; 15(4):399-404. PubMed ID: 15243212
[TBL] [Abstract][Full Text] [Related]
16. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.
Mackness MI; Arrol S; Abbott C; Durrington PN
Atherosclerosis; 1993 Dec; 104(1-2):129-35. PubMed ID: 8141836
[TBL] [Abstract][Full Text] [Related]
17. Effect of dietary lipids on paraoxonase-1 activity and gene expression.
Ferretti G; Bacchetti T
Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):88-94. PubMed ID: 22118836
[TBL] [Abstract][Full Text] [Related]
18. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
Gugliucci A
Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
[TBL] [Abstract][Full Text] [Related]
19. [Concerning the significance of paraoxonase-1 and SR-B1 genes in atherosclerosis].
Rodríguez Esparragón F; Hernández Trujillo Y; Macías Reyes A; Hernández Ortega E; Medina A; Rodríguez Pérez JC
Rev Esp Cardiol; 2006 Feb; 59(2):154-64. PubMed ID: 16540037
[TBL] [Abstract][Full Text] [Related]
20. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification.
Mackness B; Mackness MI; Arrol S; Turkie W; Durrington PN
FEBS Lett; 1998 Feb; 423(1):57-60. PubMed ID: 9506841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
